Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation

Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation

Bibliographic Details
Main Authors: Girish Gilly Munavalli, MD, MHS, FACMS, Siri Knutsen-Larson, MD, Mary P. Lupo, MD, Roy G. Geronemus, MD
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:JAAD Case Reports
Subjects:
angiotensin-converting enzyme inhibitor
angiotensin II
COVID-19
delayed inflammatory reaction (DIR)
dermal filler
delayed inflammatory reaction
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512621001375

Internet

http://www.sciencedirect.com/science/article/pii/S2352512621001375

Similar Items